{"denoms":[{"counts":[{"groupId":"BG000","value":"62"},{"groupId":"BG001","value":"135"},{"groupId":"BG002","value":"197"}],"units":"Participants"}],"groups":[{"description":"Matching placebo tablets taken once a day","id":"BG000","title":"Placebo"},{"description":"Eltrombopag 50 mg oral tablets taken once a day (QD)","id":"BG001","title":"Eltrombopag 50 mg QD"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"14.72","value":"51.0"},{"groupId":"BG001","spread":"15.61","value":"46.5"},{"groupId":"BG002","spread":"15.45","value":"47.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"93"},{"groupId":"BG002","value":"136"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"42"},{"groupId":"BG002","value":"61"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}],"title":"African American/African"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"12"}]}],"title":"American Indian/Alaska native"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"29"}]}],"title":"East Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}]}],"title":"South-East Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"Native Hawaiian or other Pacific Islander"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"8"}]}],"title":"White/Arabic/North African"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"95"},{"groupId":"BG002","value":"137"}]}],"title":"White/Caucasian/European"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}]}],"title":"Mixed Race"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"94"}]}],"title":"Use of ITP medication at randomization"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"71"}]}],"title":"Splenectomy at randomization"},{"categories":[{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"97"}]}],"title":"Platelet count less or equal 15,000 per microliter"}],"description":"Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count","paramType":"NUMBER","title":"Stratification variable","unitOfMeasure":"Participants"}]}